Clinical Trial Update: Safety and Efficacy Study of Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells to Treat Myelodysplastic Syndromes [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the safety and efficacy of umbilical cord/placenta-derived mesenchymal stem cells for treating myelodysplastic syndromes. Curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells (mesenchymal stem cells)

Snippet

Sponsor: Shandong University | Conditions: Myelodysplastic Syndromes | Phase 2 | Status: UNKNOWN